Beauty Health Co
For the period ended Dec 31, 2024. Filed Mar 12, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 12, 2025
SKIN$15.71+51.8%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except for share amounts)
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash, cash equivalents, and restricted cash | $370,063 | $523,025 |
| Accounts receivable, net of allowances for estimated credit losses of $9,597 and $6,604 at December 31, 2024 and December 31, 2023, respectively | 27,643 | 54,697 |
| Inventories | 69,113 | 91,321 |
| Income tax receivable | 818 | 332 |
| Prepaid expenses and other current assets | 9,487 | 28,877 |
| Total current assets | 477,124 | 698,252 |
| Property and equipment, net | 5,978 | 14,226 |
| Right-of-use assets, net | 13,590 | 12,120 |
| Intangible assets, net | 47,512 | 62,123 |
| Goodwill | 123,499 | 125,818 |
| Deferred income tax assets, net | 3,894 | 531 |
| Other assets | 14,086 | 16,043 |
| TOTAL ASSETS | $685,683 | $929,113 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $21,941 | $44,768 |
| Accrued payroll-related expenses | 17,636 | 22,028 |
| Lease liabilities, current | 5,147 | 4,598 |
| Income tax payable | 3,426 | 2,759 |
| Syndeo Program reserves | — | 21,009 |
| Other accrued expenses | 20,002 | 19,846 |
| Total current liabilities | 68,152 | 115,008 |
| Lease liabilities, non-current | 10,813 | 9,319 |
| Deferred income tax liabilities, net | 396 | 702 |
| Warrant liabilities | 488 | 3,555 |
| Convertible senior notes, net | 552,198 | 738,372 |
| Other long-term liabilities | 1,833 | 2,767 |
| Total liabilities | 633,880 | 869,723 |
| Commitments (Note 8) | ||
| Stockholders’ equity: | ||
| Class A Common Stock, $0.0001 par value; 320,000,000 shares authorized; 124,924,185 and 122,899,002 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively | 12 | 12 |
| Additional paid-in capital | 566,709 | 541,281 |
| Accumulated other comprehensive loss | (6,953) | (3,036) |
| Accumulated deficit | (507,965) | (478,867) |
| Total stockholders’ equity | 51,803 | 59,390 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $685,683 | $929,113 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.